KalVista Pharmaceuticals (KALV) Other Non-Current Assets (2014 - 2025)

KalVista Pharmaceuticals (KALV) has 12 years of Other Non-Current Assets data on file, last reported at $2.4 million in Q3 2025.

• For the quarter ending Q3 2025, Other Non-Current Assets rose 292.89% year-over-year to $2.4 million; the trailing twelve-month figure through Jul 2025 stood at $2.4 million (up 292.89% YoY), and the FY2025 full-year result was $1.5 million, up 173.02% from the prior year.
• Other Non-Current Assets advanced to $2.4 million in Q3 2025, from $1.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q3 2025 to a low of $106000.0 in Q2 2023.
• A 5-year average of $518736.8 and a median of $200000.0 in 2021 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets tumbled 51.38% in 2023 and surged 470.75% in 2024, its largest moves.
• Tracing KALV's Other Non-Current Assets over 5 years: stood at $193000.0 in 2021, then climbed by 2.07% to $197000.0 in 2022, then surged by 71.07% to $337000.0 in 2023, then surged by 309.2% to $1.4 million in 2024, then jumped by 72.37% to $2.4 million in 2025.
• Business Quant data shows KALV's Other Non-Current Assets at $2.4 million in Q3 2025, $1.5 million in Q2 2025, and $1.4 million in Q4 2024.